Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydrophobic tag-based protein degradation: Development, opportunity and challenge
Qindi He, Xiaofei Zhao, Donglin Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115741-115741
Closed Access | Times Cited: 17

Showing 17 citing articles:

Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
Qiao‐Hong Chen, Erick Munoz, Dennis Ashong
Cancers (2024) Vol. 16, Iss. 3, pp. 663-663
Open Access | Times Cited: 11
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 10
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025)
Open Access
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 17
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment
Wenjian Min, Huanaoyu Yang, Dawei Wang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 3
The design, synthesis and bioactivity evaluation of novel androgen receptor degraders based on hydrophobic tagging
Ying Sun, Huating Wang, Yaru Li, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107309-107309
Closed Access | Times Cited: 2
Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6)
Hongling Yang, Qiangsheng Zhang, Shuyan Zhou, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107439-107439
Closed Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of RSL3-based GPX4 Degraders with Hydrophobic Tags
Yao Ning, Zeqi Zhu, Yi‐Cheng Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116719-116719
Closed Access | Times Cited: 2
Development of natural product-based targeted protein degraders as anticancer agents
Cheng Chen, Yanyan Feng, Chen Zhou, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107772-107772
Closed Access | Times Cited: 1
Identification of inhibitors targeting the FLT3-ITD mutation through 4D-QSAR, in vitro, and in silico
Dongchen Chu, Cuicui Ji, Liang Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117089-117089
Closed Access | Times Cited: 1
Development of Novel Silicon-Based Hydrophobic Tags (SiHyT) for Targeted Proteins Degradation
Ma Lan, Kun Zhang, Ziqi Huang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER+ breast cancer
Bingsi Wang, Mingxu Ma, Yusen Dai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115934-115934
Closed Access | Times Cited: 3
Novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1
Jieke Gao, Yongli Xie, Jiantao Zhang, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3038-3047
Closed Access
Overview of the PRMT6 Modulators in Cancer Treatment: Current Progress and Emerged Opportunity
Jinjin Peng, Bin Ni, Deping Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116857-116857
Closed Access
An overview of GPX4-targeting TPDs for cancer therapy
Xiaojuan Yang, Liqiang Wu, Shaohong Xu
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118046-118046
Closed Access
Recent Advances in Developing Targeted Protein Degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
Page 1

Scroll to top